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Introduction. In patients with chronic hepatitis C, the viral infection is a constant trigger of 
inflammation, which subsequently induces formation of fibrosis (Sangiovanni A, 2006), which 
lead to portal hypertension and hepatocarcinogenesis (Pungpapong S, 2007). Until recently, 
liver fibrosis and cirrhosis were regarded as irreversible processes (Bonis PA, 2001), however, 
several studies have reported that regression of liver fibrosis can be achieved using potent 
antiviral agents (DAA) in patients with chronic hepatitis C by improving hepatic 
necroinflammation and alleviating damage. 
Aim of the study. This review aims to summarize current researches that assessed the impact 
of HCV direct-acting antiviral (DAA) therapy on changes in liver fibrosis (stiffness – LS) 
measured by transient electrography. 
Materials and methods. A literature review of the articles published on HINARI and Pubmed 
databases between 2014 and 2020 years was done. To identify relevant studies on this topic we 
used the key words: „hepatitis C”, „ direct-acting antiviral”, sustained virological response”, 
„hepatic fibrosis”, “and liver stiffness”. We analyzed about 40 different researches and 
compared the results that they provide.   
Results. We compared fibroscan data of different studies that were collected at the baseline 
(T0) and at the end of interferon-free treatment (EoT) in patients with HCV infection. SVR 
was reached in about 97.5% cases. On the whole, LS decreases by 15-35% at the EoT 
(Bachofner JA, 2017, V. Knop, 2016). One year after treatment, LS decreases by an additional 
15%, suggestive of fibrosis regression (Laursen, et al., 2019). Factors associated with a 
reduction in fibrosis as measured were lower BMI, bilirubin, FIB-4, and LS by transient 
elastography, as well as higher liver fibrosis value at registry enrollment (Ira Jacobson, 2019), 
SVR was associated significantly with this reduction  (Dolmazashvili E, 2017). Failure to 
achieve improvement in liver stiffness were associated with relapses, low baseline liver 
stiffness measurement (A. Elsharkawy, 2017), baseline high glucose, low ALT, low platelets, 
presence of esophageal varices (Persico M, 2018).  
Conclusions. In HCV patients with advanced fibrosis, pretreatment LS significantly reduced 
during DAA therapy, SVR was the only independent factor associated with this regression.  
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Introduction. The positive diagnosis of death is an important task in forensic medicine. It can 
be established by the forensic doctor or any other doctor of another specialty. The pathologist 
is often asked for an opinion on postmortem interval (PMI) based on the pathological findings. 
Estimating the time of death is of a great importance for the criminal investigation bodies, in 
regards to the possibility of justifying a version of actions, to gather evidence that can support 
or deny the states of action of suspect in a crime.  
Aim of the study. Finding the best methods that can provide us with accurate information 
regarding the estimation of death time.  
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Materials and methods. Bibliographic sources (Hinari, Goali, Medscape, University Library, 
Color Atlases).  
Results. The time of death can be approximately estimated based on the supravital reaction 
(mechanical or electrical muscular excitability, pharmacological excitability of the iris 
muscle); cadaverous changes: early (dehydration, cooling, livor mortis, rigor mortis) and 
belated changes (putrefaction), destruction by animals or insects/entomology studies (flies); 
biochemical changes (level of potassium in the vitreous body or CSF). There are a lot of 
extrinsic (temperature, humidity, environment) and intrinsic (cause of death, weight, 
comorbidities) factors that influence the process of estimating the postmortem interval and the 
error ranges for the majority of these approaches are uncomfortably large.  
Conclusions. The exact time of death can not be estimated. For a better result it is advised to 
use more than one method at a time. While none of the changes after death is capable of 
providing a precise marker of time since death, the most reliable would appear to be related to 
the cooling of the body after death, using Henssge`s Nomogram (which can be used at the death 
scene). The more time passes, the difficult it is to determine the PMI. For bodies older than 3 
days it is the best to determine the time of death by using the entomology research, using the 
stages of evolution of the insects.  
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Introduction. The distribution of patients with tuberculosis in age groups is very heterogenous 
worldwide. It reflects the social inequalities, barriers in health care accessibility and the rate of 
comorbid groups. Individuals older than 65 years are more predisposed for the sickness in 
countries with low burden of tuberculosis and those younger than 35 years–in high burden 
countries.  
Aim of the study. To study the particularities of patients with pulmonary tuberculosis older 
than 65 years and to identify the final outcome in mun. Chisinau.  
Materials and methods. A retrospective, longitudinal and selective study which included 92 
patients diagnosed with tuberculosis during 2018 in Chisinau was performed.  
Results. Assessing the gender distribution men were 66 (72%) and women 26 (28%). The 
average age was 73 years. One half, 43 (46%) were detected by the family doctor through the 
examination of symptomatic cases and through the active screening - 12 (13%) cases. 
Pulmonologist detected 15 (16%) investigating the symptomatic cases and 10 (18%) through 
the radiological screening. Were addressed to the specialized hospital 12 (13%) cases. 
Associated to tuberculosis were diagnosed in 87 (94%) one or more comorbidities. Distribution 
by groups depending on the type of case: new cases 64 (70%), cases of relapse 18 (19%), 
recovered after loss of supervision 6 (6%), after therapeutic failure 4 (5%). Distribution 
